Related Experiment Video
Updated: Feb 15, 2026

Differentiation of Atrial Cardiomyocytes from Pluripotent Stem Cells Using the BMP Antagonist Grem2
Published on: March 10, 2016
Aryl Hydrocarbon Receptor Antagonists Mitigate the Effects of Dioxin on Critical Cellular Functions in
Chawon Yun1,2, Karina M Katchko3,4, Michael S Schallmo5,6
1Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. yunchawon@hotmail.com.
Abstract:
The inhibition of bone healing in humans is a well-established effect associated with cigarette smoking, but the underlying mechanisms are still unclear. Recent work using animal cell lines have implicated the aryl hydrocarbon receptor (AhR) as a mediator of the anti-osteogenic effects of cigarette smoke, but the complexity of cigarette smoke mixtures makes understanding the mechanisms of action a major challenge. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, dioxin) is a high-affinity AhR ligand that is frequently used to investigate biological processes impacted by AhR activation. Since there are dozens of AhR ligands present in cigarette smoke, we utilized dioxin as a prototype ligand to activate the receptor and explore its effects on pro-osteogenic biomarkers and other factors critical to osteogenesis using a human osteoblast-like cell line. We also explored the capacity for AhR antagonists to protect against dioxin action in this context. We found dioxin to inhibit osteogenic differentiation, whereas co-treatment with various AhR antagonists protected against dioxin action. Dioxin also negatively impacted cell adhesion with a corresponding reduction in the expression of integrin and cadherin proteins, which are known to be involved in this process. Similarly, the dioxin-mediated inhibition of cell migration correlated with reduced expression of the chemokine receptor CXCR4 and its ligand, CXCL12, and co-treatment with antagonists restored migratory capacity. Our results suggest that AhR activation may play a role in the bone regenerative response in humans exposed to AhR activators, such as those present in cigarette smoke. Given the similarity of our results using a human cell line to previous work done in murine cells, animal models may yield data relevant to the human setting. In addition, the AhR may represent a potential therapeutic target for orthopedic patients who smoke cigarettes, or those who are exposed to secondhand smoke or other environmental sources of aryl hydrocarbons.
Insights
Aryl hydrocarbon receptor (AhR) activation by dioxin inhibits human bone healing by impairing osteogenic differentiation, cell adhesion, and migration. AhR antagonists show potential for protecting against these negative effects in smokers.
Area of Science:
- Biochemistry
- Cell Biology
- Orthopedics
Background:
- Cigarette smoking inhibits human bone healing through unclear mechanisms.
- The aryl hydrocarbon receptor (AhR) is implicated in mediating these anti-osteogenic effects.
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD, dioxin) is a potent AhR ligand used to study AhR activation.
Purpose of the Study:
- To investigate the effects of AhR activation on osteogenic differentiation, cell adhesion, and migration in a human osteoblast-like cell line.
- To explore the potential of AhR antagonists in mitigating dioxin's adverse effects on bone cells.
Main Methods:
- Utilized dioxin as a prototype AhR ligand to activate the receptor in human osteoblast-like cells.
- Assessed effects on pro-osteogenic biomarkers, cell adhesion (integrin, cadherin), and cell migration (CXCR4, CXCL12).
- Evaluated the protective capacity of AhR antagonists against dioxin-induced changes.
Main Results:
- Dioxin significantly inhibited osteogenic differentiation and negatively impacted cell adhesion and migration.
- Dioxin reduced the expression of integrin, cadherin, CXCR4, and CXCL12.
- Co-treatment with AhR antagonists protected against dioxin's inhibitory actions and restored cell function.
Conclusions:
- AhR activation plays a role in impaired bone regeneration in humans exposed to AhR activators like those in cigarette smoke.
- Findings in human cells align with previous murine studies, suggesting animal models' relevance.
- The AhR presents a potential therapeutic target for individuals exposed to environmental aryl hydrocarbons, including cigarette smoke.
Related Concept Videos
Cellular Differentiation
A zygote is a...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Functional Groups
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists

